ARPANSA activities in response to COVID-19
Updated 19 November 2020
As a Federal Government Agency working under the Department of Health, ARPANSA is committed to supporting the health and safety of all Australians. During this period, as the Government works to protect the community from the effects of the novel coronavirus (COVID-19), we are working to support our staff and all stakeholders as we do our part to reduce the spread.
For up-to-date information and advice on COVID-19, please refer to the Department of Health website.
Our offices in Sydney (Miranda) and Melbourne (Yallambie) are currently closed to the public. ARPANSA maintains a reduced on-site workforce and adjustments have been made at both sites to maintain a COVID Safe workplace.
Regulatory activities are continuing, with a combination of remote and on-site inspections.
Our Australian Clinical Dosimetry Service (ACDS) has returned to more regular on-site auditing and, using remote support where practicable, continues to support the radiation oncology community to ensure clinical obligations are met.
Other laboratories and services that were temporarily unavailable during the earlier period of our response are now operational, however we anticipate some delays.
All other activities, including our Comprehensive Test Ban Treaty radionuclide monitoring system, medical permits, UV monitoring network and other radiation monitoring programs continue to operate as normal.
We will provide further updates to this advice as required.